| Press Release |
FOR IMMEDIATE RELEASE |
Silicon
Kinetics Announces Addition of Dr. Rick Brown and Dr. Eric Topol
|
Most
recently, Dr. Brown has co-founded AVIA Biosystems to develop new biophysical
methods to assess protein stability. Dr. Rick
Brown joined MicroCal after Isis Pharmaceuticals, where he served as Vice
President of Business Development and President of Isis’ functional genomics
division, GeneTrove. Before Isis,
Dr. Brown’s career included five years with Discovery Partners International
(DPII) as President of IRORI, one of DPII operating companies, providing
automated chemical synthesis systems and services to drug discovery
laboratories. Earlier, Dr. Brown spent 17 years in various functions with
companies involved in laboratory automation and analytical instruments used by
life scientists in industry and academia. He received his BS in Chemistry from
Massachusetts State College and his PhD in Chemistry from the University of
Massachusetts, Amherst.
Dr.
Eric Topol serves as the Director of Scripps Translational Science Institute, http://www.stsiweb.org/ an NIH supported establishment that bridges
clinical investigation with basic science, and trains physicians and scientists
for careers in translational research. He is also the Chief Academic Officer,
Scripps Health in San Diego, California. Prior to moving to San Diego, Dr.
Topol was the Provost and Chief Academic Officer at the Cleveland Clinic, and
Founder of the Cleveland Clinic Lerner College of Medicine. In addition to
other numerous honors and awards, in 2004 Dr. Topol was elected to the
Institute of Medicine, National Academy of Sciences. He received his BA from
the University of Virginia, and his MD from the University of Rochester, New
York.
Dr.
Kenneth Tang, Chairman and CEO of Trex Enterprises, (http://www.trexenterprises.com/) the incubator and a
major shareholder of Silicon Kinetics, also serves on the Board of Silicon
Kinetics. Prior to forming Trex Enterprises as an independent company, Dr. Tang
was Trex’ President under the umbrella of ThermoTrex Corporation, which was a
publicly held subsidiary of Thermo Electron Corporation. He also served as
Senior Vice President of ThermoTrex Corporation. In 1988, Thermo Electron
acquired Western Research Corporation, which later became ThermoTrex. Dr. Tang
was part of Western Research’s executive team and held the position of Vice
President of Technological Development. Dr. Tang received his PhD in physical
chemistry from Indiana University, and his undergraduate degree from Chung Yuan
Christian College in Taiwan.
“All
of our distinguished Directors share the same vision: developing Silicon
Kinetics as the leader in label-free biomolecular interaction analysis, with
industry-leading products and services for researchers in pharmaceutical and
biotech industries and in academia,” said Hus Tigli, Chairman of The Board and
CEO of Silicon Kinetics. “Dr. Tang and I welcome our new Directors, as they
join us to advance Silicon Kinetics to the next stages.”
About
Silicon Kinetics
Silicon
Kinetics Inc. is a privately-held life sciences tools company headquartered in
San Diego, California. The Company specializes in instruments for optical
interferometry in nano-porous silicon biochips. The SKi Pro™ instrument
platform and the 3D SKi Sensor™ biochips are used to detect protein-protein,
protein-drug, or protein-DNA interactions in real-time and quantify binding
kinetics, dissociation rates, or biomolecular affinity rankings, required for
the study of disease pathways and the development and manufacturing of
therapeutics. More information can be found at http://www.siliconkinetics.com
###
Media
contact:
Cynthia Guiang
CG
Communications
(858)
793-2471
|
Copyright © 2011 by Silicon Kinetics, Inc. 10455 Pacific Center Court San Diego, CA 92121 +1 858 646-5444